Carregant...

Immunotherapy in colorectal cancer: for the select few or all?

Over the past few years, the role of immunotherapy in colorectal cancer (CRC) has expanded, specifically in subsets of CRC with microsatellite instability (MSI) for which newer agents, such as programmed death-1 (PD-1) inhibitors, are efficacious. While other immunotherapeutic agents are more immatu...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Gastrointest Oncol
Autors principals: Arora, Sukeshi Patel, Mahalingam, Devalingam
Format: Artigo
Idioma:Inglês
Publicat: AME Publishing Company 2018
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5848030/
https://ncbi.nlm.nih.gov/pubmed/29564183
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2017.06.10
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!